G

Researcher Profile

George D Yancopoulos

5

Publications

3,321

Citations

10

Co-Authors

5

Active Years

Publications

Journal Article The Lancet Mar 01, 2024

Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial

David M Brown · David S Boyer · Diana V Do · Charles C Wykoff +151 more

10.1016/s0140-6736(23)02577-1 94 citations

Journal Article The Lancet Feb 01, 2021

Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial

Ahmet Sezer · Saadettin Kilickap · Mahmut Gümüş · Igor Bondarenko +23 more

10.1016/s0140-6736(21)00228-2 679 citations

Journal Article The Lancet Nov 01, 2019

Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

Claus Bachert · Joseph K Han · Martin Desrosiers · Peter W Hellings +30 more

10.1016/s0140-6736(19)31881-1 1,261 citations

Journal Article The Lancet Jun 01, 2017

Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

Andrew Blauvelt · Marjolein de Bruin-Weller · Melinda Gooderham · Jennifer C Cather +27 more

10.1016/s0140-6736(17)31191-1 1,069 citations

Open Access Journal Article Nature Biotechnology Dec 24, 2006

F0 generation mice fully derived from gene-targeted embryonic stem cells allowing immediate phenotypic analyses

William T Poueymirou · Wojtek Auerbach · David Frendewey · Joseph F Hickey +10 more

10.1038/nbt1263 218 citations

Publication Timeline

2024

1

2021

1

2019

1

2017

1

2006

1

Frequent Co-Authors

Neil M H Graham

Gianluca Pirozzi

Tanya M Laidlaw